Glycan microarray analysis of tumor-associated antibodies

Anticarbohydrate Antibodies: From Molecular Basis to Clinical Application

Volumn 9783709108703, Issue , 2012, Pages 283-306

  Blixt, Ola ^a   Boos, Irene ^a   Mandel, Ulla ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930607222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0870-3_12     Document Type: Chapter

References (86)

1. Abe K, McKibbin JM, Hakomori S. (1983). The monoclonal antibody directed to difucosylated type 2 chain (Fuca12Galb14[Fuca13]GlcNAc; Y determinant) . J Biol Chem 258 (19): 11793-11797
2. Abe K, Levery SB, Hakomori S. (1984). The antibody specific to type 1 chain blood group A determinant. J Immunol 132 (4): 1951-1954
3. Altmann F. (2007). The role of protein glycosylation in allergy. Int Arch Allergy Immunol 142 (2): 99-115
4. Alvarez RA, Blixt O. (2006). Identification of ligand specificities for glycan-binding proteins using glycan arrays. Methods Enzymol 415: 292-310
5. Berger EG. (1999). Tn-syndrome. Biochim Biophys Acta 1455 (2-3): 255-268
6. Blixt O, Razi N. (2006). Chemoenzymatic synthesis of glycan libraries. Methods Enzymol 415: 137-153
7. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J, Razi N, Stevens DJ, Skehel JJ, van Die I, Burton DR, Wilson IA, Cummings R, Bovin N, Wong CH, Paulson JC. (2004). Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 101 (49): 17033-17038
8. Blixt O, Kumagai-Braesch M, Tibell A, Groth CG, Holgersson J. (2009). Anticarbohydrate antibody repertoires in patients transplanted with fetal pig Islets revealed by glycan arrays. Am J Transplant 9 (1): 83-90
9. Blixt O, Clo E, Nudelman AS, Sorensen KK, Clausen T, Wandall HH, Livingston PO, Clausen H, Jensen KJ. (2010). A high-throughput O-glycopeptide discovery platform for seromic profiling. J Proteome Res 9 (10): 5250-5261
10. Blixt O, Bueti D, Burford B, Allen D, Julien S, Hollingsworth M, Gammerman A, Fentiman I, Taylor-Papadimitriou J, Burchell JM. (2011). Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res 13 (2): R25
11. Bohm CM, Mulder MC, Zennadi R, Notter M, Schmitt-Graff A, Finn OJ, Taylor-Papadimitriou J, Stein H, Clausen H, Riecken EO, Hanski C. (1997). Carbohydrate recognition on MUC1- expressing targets enhances cytotoxicity of a T cell subpopulation. Scand J Immunol 46 (1): 27-34
12. Breimer ME, Brynger H, Le Pendu J, Oriol R, Rydberg L, Samuelsson BE, Vinas J. (1987). Blood group ABO-incompatible kidney transplantation biochemical and immunochemical studies of blood group A glycolipid antigens in human kidney and characterization of the antibody response (antigen specificity and antibody class) in O recipients receiving A2 grafts. Transplant Proc 19 (1 Pt 1): 226-230
13. Canevari S, Fossati G, Balsari A, Sonnino S, Colnaghi MI. (1983). Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells. Cancer Res 43 (3): 1301-1305
14. Clausen H, Holmes E, Hakomori S. (1986). Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H) . II. Differential conversion of different H substrates by A1 and A2 enzymes, and type 3 chain H expression in relation to secretor status. J Biol Chem 261 (3): 1388-1392
15. Clausen H, Stroud M, Parker J, Springer G, Hakomori S. (1988). Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen. Mol Immunol 25 (2): 199-204
16. Coltart DM, Royyuru AK, Williams LJ, Glunz PW, Sames D, Kuduk SD, Schwarz JB, Chen XT, Danishefsky SJ, Live DH. (2002). Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomains. J Am Chem Soc 124 (33): 9833-9844
17. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Lees A, Kieber-Emmons T. (2001). Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development. Vaccine 19 (17-19): 2361-2368
18. Dabelsteen E. (1996). Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 179 (4): 358-369
19. Dausset J, Moullec J, Bernard J. (1959). Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn) . Blood 14: 1079-1093
20. Dessureault S, Koven I, Reilly RM, Couture J, Schmocker B, Damani M, Kirsh J, Ichise M, Sidlofsky S, McEwan AJ, Boniface G, Stern H, Gallinger S. (1997). Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170 H.82 (Tru-Scint AD) . Breast Cancer Res Treat 45 (1): 29-37
21. Fukushi Y, Hakomori S, Nudelman E, Cochran N. (1984). Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259 (7): 4681-4685
22. Fukushi Y, Kannagi R, Hakomori S, Shepard T, Kulander BG, Singer JW. (1985). Location and distribution of difucoganglioside (sialyl dimeric Lex) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res 45 (8): 3711-3717
23. Geng D, Shankar G, Schantz A, Rajadhyaksha M, Davis H, Wagner C. (2005). Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies. J Pharm Biomed Anal 39 (3-4): 364-375
24. Hakomori SI. (1978). Isolation of blood group ABH-active glycolipids from human erythrocyte membranes. Methods Enzymol 50: 207-211
25. Hakomori S. (1984). Tumor-associated carbohydrate antigens. Annu Rev Immunol 2: 103-126
26. Hakomori S. (1985). Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 45 (6): 2405-2414
27. Heimburg J, Yan J, Morey S, Glinskii OV, Huxley VH, Wild L, Klick R, Roy R, Glinsky VV, Rittenhouse-Olson K. (2006). Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 8 (11): 939-948
28. Heimburg-Molinaro J, Rittenhouse-Olson K. (2009). Development and characterization of antibodies to carbohydrate antigens. Methods Mol Biol 534: 341-357
29. Hirakawa J, Tsubo1 K, Sato K, Kobayashi M, Watanabe S, Takakura A, Imai Y, Ito Y, Fukuda M, Kawashima H. (2010). Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing. J Biol Chem 285 (52): 40864-40878
30. Hirohashi S, Clausen H, Yamada T, Shimosato Y, Hakomori S. (1985). Blood group A crossreacting epitope defined by monoclonal antibodies NCC-LU-35 and 81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proc Natl Acad Sci USA 82 (20): 7039-7043
31. Huang CY, Thayer DA, Chang AY, Best MD, Hoffmann J, Head S, Wong CH. (2006). Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen. Proc Natl Acad Sci USA 103 (1): 15-20
32. Inagaki Y, Xu H, Nakata M, Seyama Y, Hasegawa K, Sugawara Y, Tang W, Kokudo N. (2009). Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. Biosci Trends 3 (6): 220-232
33. Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, Heinzelmann-Schwarz V. (2011). Serum anti-glycan antibody detection of non-mucinous ovarian cancers by using a printed glycan array. Int J Cancer, in press
34. Kaltgrad E, Sen Gupta S, Punna S, Huang CY, Chang A, Wong CH, Finn MG, Blixt O. (2007). Anti-carbohydrate antibodies elicited by polyvalent display on a viral scaffold. Chembiochem 8 (12): 1455-1462
35. Kannagi R, Hakomori S. (2001). A guide to monoclonal antibodies directed to glycotopes. Adv Exp Med Biol 491: 587-630
36. Kannagi R, Nudelman E, Levery SB, Hakomori S. (1982). A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem 257 (24): 14865-14874
37. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG. (1995). A new monoclonal-antibody (A78-G/A7) to the Thomsen-Friedenreich pantumor antigen. Hybridoma 14 (1): 37-44
38. Kato K, Takeuchi H, Ohki T, Waki M, Usami K, Hassan H, Clausen H, Irimura T. (2008). A lectin recognizes differential arrangements of O-glycans on mucin repeats. Biochem Biophys Res Commun 371 (4): 698-701
39. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S. (1988). Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2 6a-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 48 (8): 2214-2220
40. Köhler G, Milstein C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256. (5517).: 495-497
41. Koprowski H, Herlyn M, Steplewski Z, Sears HF. (1981). Specific antigen in serum of patients with colon carcinoma. Science 212. (4490).: 53-55
42. Kracun SK, Clo E, Clausen H, Levery SB, Jensen KJ, Blixt O. (2010). Random glycopeptide bead libraries for seromic biomarker discovery. J Proteome Res 9 (12): 6705-6714
43. Kurosaka A, Kitagawa H, Fukui S, Numata Y, Nakada H, Funakoshi I, Kawasaki T, Ogawa T, Iijima H, Yamashina I. (1988). A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha (2-6) GalNAc, in mucin-type glycoproteins. J Biol Chem 263 (18): 8724-8726
44. Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Shljapnikova L. (2005). IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, aGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival. Exp Oncol 27 (2): 136-140
45. Larkin M, Knapp W, Stoll MS, Mehmet H, Feizi T. (1991). Monoclonal antibodies VIB-E3, IB5 and HB9 to the leucocyte/epithelial antigen CD24 resemble BA-1 in recognizing sialic acid-dependent epitope (s) . Evidence that VIB-E3 recognizes NeuAca2-6GalNAc and NeuAca2-6Gal sequences. Clin Exp Immunol 85 (3): 536-541
46. Lawrie CH, Marafioti T, Hatton CS, Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K, Banham AH. (2006). Cancer-associated carbohydrate identification in Hodgkin?s lymphoma by carbohydrate array profiling. Int J Cancer 118 (12): 3161-3166
47. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M. (2001). ABH and Lewis histo-blood group antigens in cancer. APMIS 109 (1): 9-31
48. Li Q, Anver MR, Butcher DO, Gildersleeve JC. (2009). Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines. Mol Cancer Ther 8 (4): 971-979
49. Li Q, Rodriguez LG, Farnsworth DF, Gildersleeve JC. (2010). Effects of hapten density on the induced antibody repertoire. Chembiochem 11 (12): 1686-1691
50. Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, Steplewski Z, Koprowski H. (1981). A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma Science 212: 55-6
51. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V. (1982). A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257 (23): 14365-14369
52. Mandel U, Petersen OW, Sorensen H, Vedtofte P, Hakomori S, Clausen H, Dabelsteen E. (1991). Simple mucin-type carbohydrates in oral stratified squamous and salivary gland epithelia. J Invest Dermatol 97 (4): 713-721
53. Mandel U, Langkilde NC, Orntoft TF, Therkildsen MH, Karkov J, Reibel J, White T, Clausen H, Dabelsteen E. (1992). Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression. Int J Cancer 52 (1): 7-12
54. Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi I, Fukui S, Mellors A, Yamashina I. (1993). Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128) . Proc Natl Acad Sci USA 90 (6): 2495-2499
55. Nelson AL, Dhimolea E, Reichert JM. (2010). Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9 (10): 767-774
56. Nemoto Y, Izumi Y, Tezuka K, Tamatani T, Irimura T. (1998). Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion. Clin Exp Metastasis 16 (6): 569-576
57. Nuti M, Teramoto YA, Mariani-Costantini R, Hand PH, Colcher D, Schlom J. (1982). A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer 29 (5): 539-545
58. Ohyabu N, Hinou H, Matsushita T, Izumi R, Shimizu H, Kawamoto K, Numata Y, Togame H, Takemoto H, Kondo H, Nishimura S. (2009). An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. J Am Chem Soc 131 (47): 17102-17109
59. Ozawa H, Kotani M, Kawashima I, Tai T. (1992). Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta 1123 (2): 184-190
60. Reddish MA, Jackson L, Koganty RR, Qiu D, Hong W, Longenecker BM. (1997). Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconj J 14 (5): 549-560
61. Rillahan CD, Paulson JC. (2010). Glycan microarrays for decoding the glycome. Annu Rev Biochem 2011 (80): 797-823
62. Rinaldi S, Brennan KM, Goodyear CS, O?Leary C, Schiavo G, Crocker PR, Willison HJ. (2009). Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 19 (7): 789-796
63. Rouger P, Tsikas G, Gane P, Oriol R, Salmon C. (1987). Immunological approach of anti-H (9) , anti-Lewis (6) , anti-P (3) and anti-Pr (1) monoclonal antibodies. Rev Fr Transfus Immunohematol 30 (5): 663-669
64. Sawada R, Sun SM, Wu X, Hong F, Ragupathi G, Livingston PO, Scholz WW. (2011). Human monoclonal antibodies to sialyl-LewisA (CA19.9) with potent CDC, ADCC, and antitumor activity. Clin Cancer Res 17 (5): 1024-1032
65. Seeberger PH. (2008). Automated oligosaccharide synthesis. Chem Soc Rev 37 (1): 19-28
66. Shitara K, Hanai N, Yoshida H. (1987). Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Cancer Res 47 (5): 1267-1272
67. Singhal AK, Orntoft TF, Nudelman E, Nance S, Schibig L, Stroud MR, Clausen H, Hakomori S. (1990). Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma Cancer Res 50: 1375-80
68. Sorensen AL, Reis CA, Tarp MA, Mandel U, Ramachandran K, Sankaranarayanan V, Schwientek T, Graham R, Taylor-Papadimitriou J, Hollingsworth MA, Burchell J, Clausen H. (2006). Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Glycobiology 16 (2): 96-107
69. Springer GF. (1984). T and Tn, general carcinoma autoantigens. Science 224. (4654).: 1198-1206
70. Springer GF. (1989). Tn epitope (N-acetyl-D-galactosamine a-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 26 (1): 1-5
71. Springer GF. (1997). Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 75 (8): 594-602
72. Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K, Hasegawa A, Kannagi R. (1991). Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 179 (2): 713-719
73. Takeuchi H, Kato K, Denda-Nagai K, Hanisch FG, Clausen H, Irimura T. (2002). The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl a 2-3galactosyl b1-3 N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat. J Immunol Methods 270 (2): 199-209
74. Tan HT, Low J, Lim SG, Chung MC. (2009). Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276 (23): 6880-6904
75. Thurin J, Thurin M, Herlyn M, Elder DE, Steplewski Z, Clark WH Jr, Koprowski H. (1986). GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression. FEBS Lett 208 (1): 17-22
76. Thurnher M, Clausen H, Sharon N, Berger EG. (1993). Use of O-glycosylation-defective human lymphoid cell lines and flow cytometry to delineate the specificity of Moluccella laevis lectin and monoclonal antibody 5 F4 for the Tn antigen (GalNAc a1-O-Ser/Thr) . Immunol Lett 36 (3): 239-243
77. Tarp MA, Sorensen AL, Mandel U, Paulsen H, Burchell J, Taylor-Papadimitriou J, Clausen H. (2007). Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat Glycobiology 17: 197-209
78. von Gunten S, Smith DF, Cummings RD, Riedel S, Miescher S, Schaub A, Hamilton RG, Bochner BS. (2009). Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass. J Allergy Clin Immunol 123 (6): 1268-1276
79. Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Papadimitriou JT, Burchell J, Clausen H. (2010). Autoantibody signatures to aberrant O-glycopeptide epitopes serve as undiscovered biomarkers of cancer. Cancer Res 70 (4): 1306-1313
80. Wang CC, Huang YL, Ren CT, Lin CW, Hung JT, Yu JC, Yu AL, Wu CY, Wong CH. (2008). Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci USA 105 (33): 11661-11666
81. Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R, Ferrone S, Tsao CY, Herlyn D. (2008). Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother 57 (7): 1079-1089
82. Xu Y, Gendler SJ, Franco A. (2004). Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas. J Exp Med 199 (5): 707-716
83. Young WW Jr, MacDonald EM, Nowinski RC, Hakomori SI. (1979). Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2) . J Exp Med 150 (4): 1008-1019
84. Young WW Jr, Portoukalian J, Hakomori S. (1981). Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem 256 (21): 10967-10972
85. Yuasa N, Zhang W, Goto T, Sakaue H, Matsumoto-Takasaki A, Kimura M, Ohshima H, Tsuchida Y, Koizumi T, Sakai K, Kojima T, Yamamoto K, Nakata M, Fujita-Yamaguchi Y. (2010). Production of anti-carbohydrate antibodies by phage display technologies: potential impairment of cell growth as a result of endogenous expression. J Biol Chem 285 (40): 30587-30597
86. Zhang S, Zhang HS, Reuter VE, Slovin SF, Scher HI, Livingston PO. (1998). Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res 4 (2): 295-302